Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration
Titel:
Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration
Auteur:
Mountzios, G. Remon, J. Novello, S. Blais, N. Califano, R. Cufer, T. Dingemans, A.M. Liu, S.V. Peled, N. Pennell, N.A. Reck, M. Rolfo, C. Tan, D. Vansteenkiste, J. West, H. Besse, B.